Juan Carlos Leza, new director of the Complutense Foundation

Pharmacology professor succeeds María Paz García-Vera, with María Isabel Colado joining as deputy director.

Generic image of an open medical textbook on a wooden desk, showing pharmacological diagrams and text. Warm, soft lighting.
AI

Generic image of an open medical textbook on a wooden desk, showing pharmacological diagrams and text. Warm, soft lighting.

Pharmacology professor Juan Carlos Leza Cerro has been appointed the new director of the General Foundation of the Complutense University (UCM), succeeding Psychology professor María Paz García-Vera. Pharmacology professor María Isabel Colado Megía joins as deputy director.

Juan Carlos Leza Cerro, who holds degrees in Medicine and Surgery (Pharmacology) from the UCM, takes over the Foundation's direction. He completed further training in centers in the United Kingdom and Canada and has been a professor of Pharmacology at the Faculty of Medicine since 2010. He has been a corresponding academic of the Royal Academy of Medicine of Spain since 2008.
With 40 years of teaching experience, Leza has dedicated his career to training doctors and researchers. He is the author and editor of several pharmacology textbooks and works on drug addiction, and has supervised over 20 doctoral theses. As a researcher, he coordinates the UCM research group 962075 “Molecular Neuropsychopharmacology” and is the principal investigator for CIBER of Mental Health (CIBERSAM-ISCIII).
His academic and research management experience includes roles such as head of Health Area for UCM Summer Courses, Department Secretary and Director, and a member of the UCM Governing Council. He also served as vice-president and scientific deputy director of the 12 de Octubre Hospital Research Institute.
The new deputy director, María Isabel Colado Megía, has been a professor of Pharmacology at the UCM Faculty of Medicine since 2010. Her research focuses on the neurobiological and behavioral effects of drugs of abuse, with a current interest in psilocybin for preventing methamphetamine craving.
Since 1995, she has directed the Research Group on Neurobiology of Amphetamines and Alcohol (Group UCM 910258), recognized by the AEI. She has received the Research Award in Drug Addiction Prevention from the Drug Agency of the Community of Madrid twice.
Her management experience includes serving as secretary and director of the Pharmacology Department at UCM, academic secretary of the Faculty of Medicine, and membership in the Governing Council and various university commissions.
Based on information from the official source: Universidad Complutense de Madrid — Tribuna Complutense (20/11/2026)